United States MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: July 09, 2025 Report Code: GDME25990CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States MRI Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States MRI Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

The United States MRI Systems Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for MRI Systems Market.
• Global corporate-level profiles of key companies operating within the United States MRI Systems Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States MRI Systems is segmented as follows –

• 3T MRI Systems

• 1.5T MRI Systems

• 0.2T-1.2T MRI Systems

Reasons to Buy

The United States MRI Systems Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Beijing Wandong Medical Technology Co Ltd
Canon Medical Systems Corp
GE HealthCare Technologies Inc
Philips Healthcare Informatics Inc
Siemens Healthineers AG

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 MRI Systems Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 7

3 MRI Systems Market, United States 8

3.1 MRI Systems Market, United States, Revenue ($m), 2018-2033 8

3.2 MRI Systems Market, United States, Volume (Units), 2018-2033 10

3.3 MRI Systems Market, United States, Average Price ($), 2018-2033 12

3.4 MRI Systems Market, United States, Company Share by Revenue ($m), 2024 13

4 Overview of Key Companies in United States, MRI Systems Market 14

4.1 Siemens Healthineers AG 14

4.1.1 Company Overview 14

4.2 GE HealthCare Technologies Inc 14

4.2.1 Company Overview 14

4.3 Philips Healthcare Informatics Inc 14

4.3.1 Company Overview 14

4.4 Canon Medical Systems Corp 14

4.4.1 Company Overview 14

5 MRI Systems Market Pipeline Products 15

6 Financial Deals Landscape 17

6.1 Debt Offerings 17

6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of

4.800% Senior Notes Due 2029 17

6.2 Equity Offerings 19

6.2.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares 19

6.2.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares 20

7 Recent Developments 21

7.1 Corporate Communications 21

7.1.1 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 21

7.1.2 Feb 21, 2025: Bruker Adds Laura Francis to Board of Directors 21

7.1.3 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 21

7.1.4 Sep 03, 2024: Butterfly Network Appoints Steve Cashman as Chief Business Officer 22

7.1.5 Sep 03, 2024: Polarean Imaging Appoints Alan Huang as Vice President of Sales 22

7.1.6 Sep 03, 2024: Polarean Imaging Announces Appointment of Vice President of Sales 23

7.2 Financial Announcements 23

7.2.1 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 23

7.2.2 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 24

7.2.3 Mar 12, 2025: Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business 25

7.2.4 Feb 27, 2025: Polarean Imaging Announces FY24 Trading Update 26

7.2.5 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 27

7.2.6 Jan 27, 2025: Progentec Diagnostics' Proprietary aiSLE DX FRI and DAI Lupus Biomarker Tests Receive PLA Codes and Final Payment Determination from the Centers of Medicare and Medicaid Services 28

7.2.7 Jan 08, 2025: Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2024 Revenue Growth of Approximately 35% Year over Year 29

7.2.8 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 29

7.2.9 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 30

7.2.10 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 30

7.2.11 Nov 12, 2024: Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 31

7.2.12 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 32

7.2.13 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 32

7.2.14 Aug 01, 2024: Butterfly Network Releases Q2 2024 Results 32

7.2.15 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 33

7.3 Government and Public Interest 34

7.3.1 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring 34

7.3.2 Feb 13, 2025: Unimom Receives Additional 510(K) Clearance For VIVACE Powered Breast Pump 34

7.3.3 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 35

7.3.4 Jan 29, 2025: Update on the Episurf MTP Implant – Response to FDA Submitted 35

7.3.5 Dec 20, 2024: FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities 35

7.3.6 Dec 03, 2024: Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed 37

7.3.7 Nov 20, 2024: IAC Releases Updates to IAC Standards & Guidelines for MRI Accreditation 37

7.3.8 Oct 29, 2024: Celltrion Presents Post Hoc Analysis of Liberty Studies of Zymfentra at the ACG 2024 Annual Scientific Meeting 38

7.3.9 Oct 15, 2024: Electronic Medical Devices, X-ray Imaging and Radiation Therapy: What to Know and How to Prevent Damage 39

7.3.10 Sep 25, 2024: Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study 40

7.3.11 Aug 23, 2024: Nurexone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences 41

7.3.12 Jul 29, 2024: Zimmer MedizinSysteme Receives FDA 510(k) Clearance for RFG-01 42

7.4 Other Significant Developments 42

7.4.1 Jun 16, 2025: Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients 42

7.4.2 May 09, 2025: Mediso Completes First Phase of Strategic Technology Transfer Agreement With Superconducting Systems 44

7.4.3 Apr 28, 2025: SLUHN Invests in AI-Enabled MRI Technology from GE HealthCare 44

7.4.4 Apr 23, 2025: Eugia Pharma Receives USFDA Approval for Dasatinib Tablets 45

7.4.5 Apr 08, 2025: 3D Printing and Visualization: A New Dimension of CT and MRI 45

7.4.6 Mar 18, 2025: Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA 46

7.4.7 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 47

7.4.8 Jan 07, 2025: InkSpace Imaging Receives Additional 510(K) Clearance For Imaging Body Array 47

7.4.9 Dec 30, 2024: Imricor Continues Global Expansion with First Sale in the Middle East 48

7.4.10 Dec 19, 2024: VSee Health Receives Teleradiology Contract With Post-Acute Care Hospital System 48

7.4.11 Nov 12, 2024: Rocket to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the AHA 2024 Late-Breaking Science Sessions 48

7.4.12 Oct 14, 2024: Norton Healthcare Acquires Groundbreaking Focused Ultrasound Technology 49

7.4.13 Sep 08, 2024: Avalyn Presents Multiple Posters on AP01 for PPF, Including MIST Phase 2B Trial Design and ATLAS Phase 1B Study Post-hoc Analyses, at ERS 2024 50

7.4.14 Jul 19, 2024: Xenon MRI System Trade-in Agreement Entered with the University of Virginia Health Hospital 51

7.5 Product News 52

7.5.1 Jun 02, 2025: New Headache Medicine Research Impacting Treatment, Prevention and Quality of Life to be Presented at the American Headache Society 67th Annual Scientific Meeting in Minneapolis, MN 52

7.5.2 May 08, 2025: Cutting-edge MRI Could Revolutionise Diagnosis of Common Heart Problem Aortic Stenosis 52

7.5.3 Mar 03, 2025: UTSW Researchers Use Focused Ultrasound to Identify Stroke Biomarkers 53

7.5.4 Feb 27, 2025: New 4D Brain Map Reveals Potential Early Warning Signs of Multiple Sclerosis 54

7.5.5 Feb 25, 2025: UH Researchers Paving the Way for New Era in Medical Imaging 55

7.5.6 Dec 10, 2024: Portable MRI Shows Promise for Expanding Brain Imaging for Alzheimer’s Disease 56

7.5.7 Nov 29, 2024: Interim Diagnostic Imaging and Modular Devices Unveil New Innovation in Mobile Medical Imaging 56

7.5.8 Oct 17, 2024: INFINITT North America Revolutionizes Breast MRI Tracking with Groundbreaking New Solution 57

7.5.9 Oct 01, 2024: Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting 57

7.5.10 Sep 17, 2024: New Method Created for Improving the Resolution of Routine Medical Images 59

7.5.11 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 59

7.5.12 Sep 06, 2024: Targeted Therapy For Parkinson's Disease: Breakthrough in Real-Time MRI-Guided Stem Cell Transplantation 60

7.5.13 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution

0.75% for Presbyopia 61

7.5.14 Aug 21, 2024: The STAR Consortium Announces a Major Milestone in Crohn's Disease Intestinal Strictures Imaging 63

7.5.15 Jul 09, 2024: Intensity Therapeutics Announces First Patient Dosed in Its Global Randomized, Phase 3 Study (Invincible-3) in Metastatic Soft Tissue Sarcoma 64

7.5.16 Jul 08, 2024: Capital Health Partnering with TVAX Biomedical to Offer Brain Cancer Immunotherapy Trial 65

7.6 Strategy And Business Planning 66

7.6.1 Jun 03, 2025: Matter Neuroscience Launches Collaboration With Stanford Medicine 66

7.6.2 May 13, 2025: Philips and NVIDIA partner to leverage AI for MR imaging 66

7.6.3 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 67

7.6.4 Jan 10, 2025: Imaging Biometrics and Prism Clinical Imaging Secure First Installation 67

7.6.5 Dec 04, 2024: Lisata and Kuva Labs partner for MR imaging agents to detect cancer 68

7.6.6 Oct 16, 2024: Ezra, Full-Body MRI Leader, Launches AI-Powered Scans to Philadelphia in Partnership with Princeton Radiology 68

7.6.7 Aug 20, 2024: Prism Clinical Imaging and Sora Neuroscience Sign Cooperation Agreement 69

7.6.8 Aug 08, 2024: Youngstown Orthopaedic Associates and The Orthopaedic Surgery Center in Youngstown Name Medline as Prime Vendor 69

7.6.9 Jun 27, 2024: Ezra Launches AI-Fueled, Whole-Body MRI in Seattle in Partnership with Imaging Leader RAYUS Radiology 70

8 Appendix 71

8.1 Research Methodology 72

8.1.1 Coverage 72

8.1.2 Secondary Research 72

8.1.3 Primary Research 72

8.1.4 Market Modeling and Forecasting 73

8.1.5 Company Share Analysis 74

8.1.6 Benchmarking 75

8.2 GlobalData Consulting 75

8.3 Contact Us 75

8.4 Disclaimer 76

Table

Table 1: MRI Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 9

Table 2: MRI Systems Market, United States, Volume (Units), 2018-2033 11

Table 3: MRI Systems Market, United States, Average Price ($), 2018-2033 12

Table 4: MRI Systems Market, United States, Company Share by Revenue ($m), 2024 13

Table 5: MRI Systems Market Pipeline Products 15

Table 6: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029 17

Table 7: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares 19

Table 8: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares 20

Table 9: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 73

Figures

Figure 1: MRI Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 8

Figure 2: MRI Systems Market, United States, Volume (Units), 2018-2033 10

Figure 3: MRI Systems Market, United States, Company Share (%), 2024 13

United States MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports

Medical Devices

New

CAD/CAM Systems and Materials Market Size by Segments, Share, Regulatory,…

Medical Devices

New

Dental Handpieces Market Size by Segments, Share, Regulatory, Reimbursement, Installed…

Medical Devices

New

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems in real time.

Access a live United States MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States MRI Systems Market Outlook to 2033: 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports